Cargando…
Favipiravir/tocilizumab: Increased lymphocyte count and transaminases following off-label use: 4 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843877/ http://dx.doi.org/10.1007/s40278-021-90336-3 |
Ejemplares similares
-
Aspirin/favipiravir: Haemolytic anaemia, decrease in his lymphocyte count and off-label use: case report
Publicado: (2021) -
Favipiravir: Erythema and transaminase elevation: case report
Publicado: (2022) -
Tocilizumab: Decrease in WBC count following an off-label use: case report
Publicado: (2020) -
Favipiravir: Liver injury following an off-label use: case report
Publicado: (2021) -
Favipiravir: Acute pancreatitis following an off-label use: case report
Publicado: (2021)